In other transgenic mouse models of AD, STZ-induced cerebral insulin depletion has also been reported to aggravate AD-like traits such as amyloid plaques, tau phosphorylation, neurofibrillary tangles, and spatial memory deficits in the Morris water maze or Barnes maze task [21]–[23], [40]. The gene discussed is MAPT; the disease is Alzheimer disease.